CLV.AX - Clover Corporation Limited

ASX - ASX Delayed Price. Currency in AUD

Clover Corporation Limited

1 International Drive
Unit 35E
Westmeadows, VIC 3049
Australia
61 3 8347 5000
http://www.clovercorp.com.au

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees33

Key Executives

NameTitlePayExercisedAge
Mr. Peter J. Davey MBA, GradDip Bus., Dip.Art, GAICDCEO, MD & Exec. Director564.14kN/AN/A
Mr. Paul A. Sherman B.Bus, CA, MBACFO & Company Sec.238.25kN/AN/A
Mr. D. PierottiOperations Mang.N/AN/AN/A
Dr. C. PatchChief Innovation OfficerN/AN/AN/A
S. PoothongChief Commercial OfficerN/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. The company is also involved in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milk products, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. The company was founded in 1988 and is headquartered in Westmeadows, Australia.

Corporate Governance

Clover Corporation Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.